4Wang XY,Zhang JT.Effects of ginsenoside Rgl on synaptic plasticity of freely moving rats and its mechanism of action.Acta Pharmacol Sin,2003,22:657-662.
5Hassiotis M,Ashwell KW,Marotte LR,et al.GAP-43 immunoreactivity in the brain of the developing and adult wallaby.Anat Embryol Berl,2002,206,97-118.
6Tolner EA,Vliet EA,Holtmaast AJ,et al.GAP-43mRNA and protein expression in the hippocampal and parahippocampal region during the course of epileptogenesis in rats.Eur J Neurosci,2003,17:2369-2380.
7Carrasco J,Penkowa M,Giralt M,et al.Role of metallothionein-Ⅲ following central nervous system damage.Neurobiol Dis,2003,13:22-36.
8McIlvain VA,Robertson DR,Maimone MM,et al.Abnormal thalamocortical pathfinding and terminal arbors lead to enlarged barrels in neonatal GAP-43 heterozygous mice.J Comp Neurol,2003,21:252-264.
9Chen B,Wang JF,Sun X.Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells.Biol Psychiatry,2003,15:530-537.
10Miljkovic LM,Silbergleit R,Fiskum G,et al.Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity.Brain Res,2003,2:90-94.
